Product Launch (Blog)

The Global Sildenafil Market is Projected to Grow at a CAGR of 4.80% During the Forecast Period

The Global Sildenafil Market is estimated to exhibit a CAGR of 4.80% during the forecast period of 2021-2028 and will be valued at USD 2,096.19 million by 2028. Presence of branded drugs and increasing prevalence of erectile dysfunction worldwide is expected to influence the growth of the market.

However, side effects caused by drugs and a strict regulatory framework may hamper the global sildenafil market.   

Global Sildenafil Market

According to Data Bridge Market Research, the sildenafil market will exhibit a significant rise in its market value. Moreover, rising awareness and increasing prevalence of diabetes and obesity also boost up the market growth. Growing geriatric population and rising healthcare expenditure act as an opportunity for market growth.

Currently, North America dominates the global sildenafil market owing to the branded drugs and high acceptance of well-recognized drugs. Europe is also expected to grow exponentially due to an established healthcare and research and development activities.  

Now the question is which are the other regions that the sildenafil market is targeting? Data Bridge Market Research has estimated a large growth in the Asia-Pacific due to the rising prevalence of erectile dysfunction causing infections, growing geriatric population, increasing government initiatives for growth of pharmaceutical industries.

For more analysis on the global sildenafil market request for a briefing with our analysts, https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-sildenafil-market

Scope of the Sildenafil Market

The global sildenafil market is segmented on the basis of countries into U.S., Canada and Mexico in North America, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC)  in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

  • All country based analysis of sildenafil market is further analysed based on maximum granularity into further segmentation. The market is also segmented on the basis of product type into branded and generics. On the basis of application, the sildenafil market is segmented into peripheral vasodilator and erectile dysfunction. On the basis of end-users, the sildenafil market is segmented into clinics, hospitals, and others. On the basis of distribution channel, the sildenafil market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.
  • Sildenafil is indicated for the treatment of erectile dysfunction in men and improves the exercise ability in adults suffering from pulmonary arterial hypertension. It treats erectile dysfunction by enhancing the blood flow to the penis and increase in blood flow by relaxing the blood.

To know more about this study, click on:https://www.databridgemarketresearch.com/reports/global-sildenafil-market        

Key Pointers Covered in the Sildenafil Market Industry Trends and Forecast to 2028

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Regulatory Framework and Changes
  • Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in Sildenafil Market Report

  • Pfizer Inc.
  •  Century Pharmaceuticals Ltd.
  •  Polpharma
  •  Deva Holdings
  •  Actavis, Inc.
  •  Accord-UK Ltd.
  •  Mantra Pharma
  •  ANGITA
  •  Apotex Inc.
  •  Bayer AG
  •  Ritz Formulations Pvt. Ltd.
  •  Cipla
  •  Abbott
  •  Viatris Inc.
  •  Sandoz
  •  Hetero Healthcare Limited
  •  Delphis Pharma
  •  Teva Pharmaceuticals USA, Inc.
  •  Lupin Pharmaceuticals, Inc.
  •  Amneal Pharmaceuticals LLC.
  •  Umang Pharmaceuticals

Above are the key players covered in the report, to know about more and exhaustive list of sildenafil market companies contact, https://www.databridgemarketresearch.com/toc/?dbmr=global-sildenafil-market

Research Methodology: Global Sildenafil Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/


Client Testimonials